Cargando…

Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance

BACKGROUND: This study aims to compare the outcomes of active surveillance (AS) in low-risk papillary thyroid carcinoma (PTC) patients with different tumor sizes and lymph node metastasis status, in order to establish appropriate management strategies. By analyzing these results, this study provides...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Wu, Ruan, Guodong, Lin, Yingli, Zhu, Jianming, Li, Zhian, Ye, Dengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513486/
https://www.ncbi.nlm.nih.gov/pubmed/37745712
http://dx.doi.org/10.3389/fendo.2023.1235006
_version_ 1785108581424562176
author Ding, Wu
Ruan, Guodong
Lin, Yingli
Zhu, Jianming
Li, Zhian
Ye, Dengfeng
author_facet Ding, Wu
Ruan, Guodong
Lin, Yingli
Zhu, Jianming
Li, Zhian
Ye, Dengfeng
author_sort Ding, Wu
collection PubMed
description BACKGROUND: This study aims to compare the outcomes of active surveillance (AS) in low-risk papillary thyroid carcinoma (PTC) patients with different tumor sizes and lymph node metastasis status, in order to establish appropriate management strategies. By analyzing these results, this study provides valuable insights for the effective management of such patients, addressing the issues and challenges associated with AS in practical clinical practice. METHODS: The study utilized the SEER database supported by the National Cancer Institute of the United States, extracting data of PTC diagnosed between 2000 and 2015. Statistical analyses were conducted using inverse probability weighting (IPTW) and propensity score matching (PSM), including Kaplan-Meier survival curves and Cox regression models, to evaluate the impact of different tumor sizes and lymph node metastasis status on thyroid cancer-specific survival (TCSS). RESULTS: A total of 57,000 PTC patients were included, with most covariates having standardized mean differences below 10% after IPTW and PSM adjustments. The TCSS of PTC with a diameter smaller than 13mm is significantly better than that of tumors with a diameter larger than 13mm, regardless of the presence of lymph node metastasis. Among PTC cases with a diameter smaller than 13mm, the TCSS of patients is similar, regardless of the presence of lymph node metastasis. However, in PTC cases with a diameter larger than 13mm, the presence of lateral neck lymph node metastasis (N1b stage) significantly impacts the TCSS, although the absolute impact on TCSS rate is minimal. CONCLUSION: The treatment strategy of AS is safe for patients with T1a stage papillary thyroid microcarcinoma (PTMC). However, for patients with T1b stage, if the tumor diameter exceeds 13mm or there is lymph node metastasis in the lateral neck region, the TCSS will be significantly affected. Nevertheless, the absolute impact on survival is relatively small.
format Online
Article
Text
id pubmed-10513486
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105134862023-09-22 Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance Ding, Wu Ruan, Guodong Lin, Yingli Zhu, Jianming Li, Zhian Ye, Dengfeng Front Endocrinol (Lausanne) Endocrinology BACKGROUND: This study aims to compare the outcomes of active surveillance (AS) in low-risk papillary thyroid carcinoma (PTC) patients with different tumor sizes and lymph node metastasis status, in order to establish appropriate management strategies. By analyzing these results, this study provides valuable insights for the effective management of such patients, addressing the issues and challenges associated with AS in practical clinical practice. METHODS: The study utilized the SEER database supported by the National Cancer Institute of the United States, extracting data of PTC diagnosed between 2000 and 2015. Statistical analyses were conducted using inverse probability weighting (IPTW) and propensity score matching (PSM), including Kaplan-Meier survival curves and Cox regression models, to evaluate the impact of different tumor sizes and lymph node metastasis status on thyroid cancer-specific survival (TCSS). RESULTS: A total of 57,000 PTC patients were included, with most covariates having standardized mean differences below 10% after IPTW and PSM adjustments. The TCSS of PTC with a diameter smaller than 13mm is significantly better than that of tumors with a diameter larger than 13mm, regardless of the presence of lymph node metastasis. Among PTC cases with a diameter smaller than 13mm, the TCSS of patients is similar, regardless of the presence of lymph node metastasis. However, in PTC cases with a diameter larger than 13mm, the presence of lateral neck lymph node metastasis (N1b stage) significantly impacts the TCSS, although the absolute impact on TCSS rate is minimal. CONCLUSION: The treatment strategy of AS is safe for patients with T1a stage papillary thyroid microcarcinoma (PTMC). However, for patients with T1b stage, if the tumor diameter exceeds 13mm or there is lymph node metastasis in the lateral neck region, the TCSS will be significantly affected. Nevertheless, the absolute impact on survival is relatively small. Frontiers Media S.A. 2023-09-07 /pmc/articles/PMC10513486/ /pubmed/37745712 http://dx.doi.org/10.3389/fendo.2023.1235006 Text en Copyright © 2023 Ding, Ruan, Lin, Zhu, Li and Ye https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ding, Wu
Ruan, Guodong
Lin, Yingli
Zhu, Jianming
Li, Zhian
Ye, Dengfeng
Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title_full Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title_fullStr Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title_full_unstemmed Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title_short Survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
title_sort survival outcomes of low-risk papillary thyroid carcinoma at different risk levels: a corollary for active surveillance
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513486/
https://www.ncbi.nlm.nih.gov/pubmed/37745712
http://dx.doi.org/10.3389/fendo.2023.1235006
work_keys_str_mv AT dingwu survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance
AT ruanguodong survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance
AT linyingli survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance
AT zhujianming survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance
AT lizhian survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance
AT yedengfeng survivaloutcomesoflowriskpapillarythyroidcarcinomaatdifferentrisklevelsacorollaryforactivesurveillance